Regeneron Pharmaceuticals Other Non-Current Liabilities 2010-2024 | REGN

Regeneron Pharmaceuticals other non-current liabilities for the quarter ending September 30, 2024 were $1.544B, a 85.44% increase year-over-year.

  • Regeneron Pharmaceuticals other non-current liabilities for 2023 were $0.854B, a 33.87% increase from 2022.
  • Regeneron Pharmaceuticals other non-current liabilities for 2022 were $0.638B, a 6.2% decline from 2021.
  • Regeneron Pharmaceuticals other non-current liabilities for 2021 were $0.68B, a 1% decline from 2020.

Regeneron Pharmaceuticals Other Non-Current Liabilities 2010-2024 | REGN

  • Regeneron Pharmaceuticals other non-current liabilities for 2023 were $0.854B, a 33.87% increase from 2022.
  • Regeneron Pharmaceuticals other non-current liabilities for 2022 were $0.638B, a 6.2% decline from 2021.
  • Regeneron Pharmaceuticals other non-current liabilities for 2021 were $0.68B, a 1% decline from 2020.